NantPharma to Acquire Third-Generation Paclitaxel from Sorrento Therapeutics in Potential US$1.3 B Deal
By Heather Cartwright & Tridisha Goswami
Pharma Deals Review: Vol 2015 Issue 6 (Table of Contents)
Published: 11 Jun-2015
DOI: 10.3833/pdr.v2015.i6.2107 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a deal potentially worth more than US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS